SJ-0211

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSJ-0211
Drug Alias Namenutlin-3 analog (University of Tennessee Health Science Center/University of Kentucky College/St Jude Children’s Research Hospital)SJ-0211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitorsTumor protein p53 stimulants
Targetsp53-binding protein Mdm-2Tumor protein p53
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee Health Science Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSt. Jude Children'S Research HospitalUniversity Of KentuckyThe University Of Tennessee Health Science Center
Active IndicationsN/A
Inactive IndicationsRetinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A